Compare Illumina vs Transgenomic
Customers evaluate the quality of Illumina's products using the following success metrics.
Overview
Illumina is 25 yrs old and is based in United States.
Illumina works to apply technologies and revolutionary assays to the analysis of genetic variation and function. It offers collaborative interactions, rapid delivery of solutions, and focuses on customers. Illumina's array-based solutions for DNA, RNA, and protein analysis serve as tools for disease research, drug development, and the development of molecular tests in the clinic. The company was founded in 1998 and is based in San Diego, California.
Transgenomic is 26 yrs old and is based in United States.
Transgenomic (NASDAQ:TBIO) is a global biotechnology company that advances personalized medicine in oncology and inherited diseases via its products and services for automated high-sensitivity genetic variation and mutation analysis. Their offerings include systems, products, discovery, and laboratory testing services to the academic and medical research, clinical laboratory, and biopharmaceutical markets in the fields of pharmacogenomics and personalized medicine. Their flagship product is ICE COLD-PCR, which enables use of liquid biopsies for mutation detection.
Demo Video
Leadership
Maneesh Jain (Founder)
Paul Kinnon (Chief Executive Officer, President)
Funding
Investors
LRG Capital Group, Comdisco Ventures
Dorset Management Corporation, Endeavor Capital Management
Product
Benefits
Products
Customers
Known Partners
Why They Buy
Information not available because Illumina has not claimed their profile.
Work for Illumina? Claim your profile by submitting an Analyst Briefing. By submitting you can
Work for Illumina?
Claim your profile now.
Information not available because Transgenomic has not claimed their profile.
Work for Transgenomic? Claim your profile by submitting an Analyst Briefing. By submitting you can
Work for Transgenomic?
Claim your profile now.
News & Analysis
Illumina has been mentioned in our research 4 times.
Transgenomic has not been mentioned in our research.
Research Articles
Expert Collections
Unicorns- Billion Dollar Startups
115 items
Synthetic Biology
382 items
Cancer
1,284 items
Pharmaceutical and biotechnology companies with cancer therapy drug candidates.
Omics
1,267 items
Companies involved in the capture, sequencing, and/or analysis of genomic, transcriptomic, proteomic, and/or metabolomic data